A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression
A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression
Not yet recruiting · NCT07686445 · Registry updated 2026-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression | CEACAM5; RAS Mutation; Solid Tumor (Phase I) | Not yet recruiting | Phase 1 | 2026-07-14 | NCT07686445 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Adlai Nortye Biopharma Co., Ltd. | 4 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Linear | Perth | Australia | 1 |
| Scientia Clinical Research | Sydney | Australia | 1 |